SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

Financial Instruments Where Carrying Value and Fair Value Differ

Fair Value of Financial Instruments
The following details our financial instruments where the carrying value and the fair value differ (amounts in millions):
		Fair Value at Reporting Date Using
Financial Instrument		As of September 30, 2013		Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Long-term obligations	$	70.9	$	0	$	70.3	$	0

Weighted-Average Shares Outstanding

The following table sets forth, for the periods indicated, shares used in our computation of the weighted-average shares outstanding, which are used to calculate our basic and diluted net (loss) income attributable to Amedisys, Inc. common stockholders (amounts in thousands):

		For the Three-Month Periods Ended September 30,		For the Nine-Month Periods Ended September 30,
		2013	2012	2013	2012
Weighted average number of shares outstanding - basic		31,505	30,055	31,102	29,741
Effect of dilutive securities:
	Stock options	0	20	0	16
	Non-vested stock and stock units	0	348	0	311
Weighted average number of shares outstanding - diluted		31,505	30,423	31,102	30,068
Anti-dilutive securities		682	196	640	233